Cyprus vs Djibouti: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Cyprus
83.0%
in 2025
Djibouti
82.0%
in 2025
Cyprus rank
104th
Djibouti rank
106th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Cyprus
- Djibouti
How they compare
Cyprus currently reports 83.0% against 82.0% in Djibouti, a difference of 1.0%.
The two have swapped places 3 times across 18 shared years of data; in 2008 it was Djibouti ahead.
Cyprus ranks 104th and Djibouti ranks 106th of 194 countries.
Across the 3 decades both report, Cyprus averaged higher in 1 and Djibouti in 1.
Head to head by decade
| Decade | Cyprus | Djibouti | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 40.5% | 55.5% | 15.0% | Djibouti |
| 2020s | 80.3% | 69.7% | 10.7% | Cyprus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Cyprus or Djibouti?
- Cyprus, at 83.0% against 82.0% in Djibouti as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Cyprus and Djibouti?
- 1.0%, with Cyprus ahead.
- How many years of comparable data are there for Cyprus and Djibouti?
- 18 years are reported by both, from 2008 to 2025.
- How do Cyprus and Djibouti rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Cyprus ranks 104th and Djibouti ranks 106th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.